4.6 Article

Association of ambient air pollution with the prevalence and incidence of COPD

期刊

EUROPEAN RESPIRATORY JOURNAL
卷 44, 期 3, 页码 614-626

出版社

EUROPEAN RESPIRATORY SOC JOURNALS LTD
DOI: 10.1183/09031936.00132213

关键词

-

资金

  1. European Community [211250]
  2. ECRHS
  3. EGEA
  4. E3N
  5. NSHD
  6. SALIA
  7. SAPALDIA
  8. European Commission
  9. Albacete: Fondo de Investigaciones Santarias [97/0035-01, 13 99/0034-01, 99/0034-02]
  10. Albacete: Hospital Universitario de Albacete
  11. Albacete: Consejeria de Sanidad
  12. Antwerp: FWO (Fund for Scientific Research) Flanders Belgium [G.0402.00]
  13. Antwerp: University of Antwerp
  14. Antwerp: Flemish Health Ministry
  15. Barcelona: Fondo de Investigaciones Sanitarias [99/0034-02, 99/0034-01]
  16. Barcelona: Red Respira [RTIC 03/11 ISC IIF]
  17. Erfurt: GSF National Research Centre for Environment and Health
  18. Erfurt: Deutsche Forschungsgemeinschaft (DFG) [FR 1526/1-1]
  19. Galdalcao: Basque Health Department
  20. Grenoble: Programme Hospitalier de Recherche Clinique-DRC de Grenoble [2610]
  21. Grenoble: Ministry of Health, Direction de la Recherche Clinique
  22. Grenoble: Ministere de l'Emploi et de la Solidarite
  23. Grenoble: Direction Generale de la Sante
  24. Grenoble: CHU de Grenoble
  25. Grenoble: Comite des Maladies Respiratoires de l'Isere
  26. Ipswich: National Asthma Campaign (UK)
  27. Norwich: National Asthma Campaign (UK)
  28. Huelva: Fondo de Investigaciones Sanitarias (FIS) [97/0035-01, 99/0034-02, 99/0034-01]
  29. Oviedo: Fondo de Investigaciones Santarias (FIS) [97/0035-01, 99/0034-02, 99/0034-01]
  30. Paris: Ministere de l'Emploi et de la Solidarite
  31. Paris: Direction Generale de la Sante
  32. Paris: UCBPharma (France)
  33. Paris: Aventis (France)
  34. Paris: Glaxo France
  35. Paris: Programme Hospitalier de Recherche Clinique-DRC de Grenoble [2610]
  36. Paris: Ministry of Health
  37. Paris: Direction de la Recherche Clinique
  38. Paris: CHU de Grenoble
  39. Pavia: Glaxo, Smith Kline Italy
  40. Pavia: Italian Ministry of University and Scientific and Technological Research (MURST)
  41. Pavia: Local University Funding for Research, (Pavia, Italy)
  42. Turin: ASL 4 Regione Piemonte (Italy)
  43. Turin: AO CTO/ICORMA Regione Piemonte (Italy)
  44. Turin: Ministero dell'Universita e della Ricerca Scientifica (Italy)
  45. Turin: Glaxo Wellcome spa (Verona, Italy)
  46. Umea: Swedish Heart Lung Foundation
  47. Umea: Swedish Foundation for Health Care Sciences and Allergy Research
  48. Umea: Swedish Asthma and Allergy Foundation
  49. Umea: Swedish Cancer and Allergy Foundation
  50. Verona: University of Verona
  51. Verona: Italian Ministry of University and Scientific and Technological Research (MURST)
  52. Verona: Glaxo, Smith Kline Italy
  53. UK Medical Research Council [U1200632239, U12309272]
  54. German state (NRW)
  55. Federal Ministries of the Environment
  56. DGUV (German statutory accident assurance) [VT 266.1]
  57. Swiss National Science Foundation [33CSCO-134276/1, 33CSCO-108796, 3247BO-104283, 3247BO-104288, 3247BO-104284, 3247-065896, 3100-059302, 3200-052720, 3200-042532, 4026-028099]
  58. Federal Office for Forest, Environment and Landscape and several Federal and Cantonal authorities
  59. Swiss National Science Foundation
  60. German research Foundation D-A-CH grant [32473BM-133148]
  61. Medical Research Council [MC_UU_12019/1, G0901214, G0801056] Funding Source: researchfish
  62. Swiss National Science Foundation (SNF) [32473BM_133148] Funding Source: Swiss National Science Foundation (SNF)
  63. MRC [MC_UU_12019/1, G0901214, G0801056] Funding Source: UKRI

向作者/读者索取更多资源

The role of air pollution in chronic obstructive pulmonary disease (COPD) remains uncertain. The aim was to assess the impact of chronic exposure to air pollution on COPD in four cohorts using the standardised ESCAPE exposure estimates. Annual average particulate matter (PM), nitrogen oxides (NOx) and road traffic exposure were assigned to home addresses using land-use regression models. COPD was defined by NHANES reference equation (forced expiratory volume in 1 s (FEV1)/forced vital capacity (FVC) less than the lower limit of normal) and the Global Initiative for Chronic Obstructive Lung Disease criterion (FEV1/FVC <0.70) and categorised by severity in non-asthmatics. We included 6550 subjects with assigned NOx and 3692 with PM measures. COPD was not associated with NO2 or PM10 in any individual cohort. In meta-analyses only NO2, NOx, PM10 and the traffic indicators were positively, although not significantly, associated with COPD. The only statistically significant associations were seen in females (COPD prevalence using GOLD: OR 1.57, 95% CI 1.11-2.23; and incidence: OR 1.79, 95% CI 1.21-2.68). None of the principal results were statistically significant, the weak positive associations of exposure with COPD and the significant subgroup findings need to be evaluated in further well standardised cohorts followed up for longer time, and with time-matched exposure assignments.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据